Dow Up 1.13% Nasdaq Up 1.41%

Vical Incorporated (VICL)

-NasdaqGS
1.25 Up 0.04(3.31%) Oct 31, 4:00PM EDT
Prev Close:1.21
Open:1.20
Bid:1.10 x 4600
Ask:1.30 x 500
1y Target Est:3.00
Beta:2.41
Next Earnings Date:N/A
Day's Range:1.17 - 1.25
52wk Range:1.01 - 1.79
Volume:1,032,494
Avg Vol (3m):561,139
Market Cap:110.76M
P/E (ttm):N/A
EPS (ttm):-0.23
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VICLUp 3.31%110.76M
GSKUp 0.78%109.36B
SNYUp 1.18%121.34B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.19
Quarterly EPS Est (Dec-14) :-0.05
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Vical Incorporated is engaged in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback